STATERA BIOPHARMA
LIVE

Serial Number

97007302

Owner

Statera Biopharma, Inc.

Attorney

Carey Kulp

Filing Date

Sep 1, 2021

Add to watchlist:

No watchlists yet
View on USPTO

STATERA BIOPHARMA Trademark

Serial Number: 97007302

STATERA BIOPHARMA is a trademark filed by Statera Biopharma, Inc. on September 1, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Statera Biopharma, Inc. (9 trademarks)

Suite 201
Fort Collins, CO 80526

Entity Type: 03

Trademark Details

Filing Date

September 1, 2021

Registration Date

Not Registered

Goods & Services

Educational services, namely, conducting classes, seminars, conferences, and workshops and distributing printed course materials in conjunction therewith; providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields

Pharmaceutical preparations and compounds for use in immune modulation, oncology, infectious diseases; pharmaceutical preparations for the treatment or prevention of immune-mediated diseases, Crohn's disease, multiple sclerosis, viral infections, HIV/AIDS, cancer, cell growth related disorders, cell proliferation related disorders, inflammatory diseases, ulcerative diseases, autoimmune diseases, autism, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines; pharmaceutical preparations and compounds for reducing side effects in cancer treatment; pharmaceutical preparations and compounds for stimulating the immune system in an immuno-compromised patient; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral supplements

Medical and pharmaceutical research services; pharmaceutical research and development

Filing History

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 2, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 19, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 18, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 14, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 14, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jan 14, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 13, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 12, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 12, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 12, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 12, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 12, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 6, 2022 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jan 18, 2022 AMPX
ASSIGNED TO LIE
Jan 15, 2022 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Jan 12, 2022 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 14, 2021 NWOS
NEW APPLICATION ENTERED
Sep 4, 2021 NWAP